AMPORE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

AMPORE Trademark

Serial Number: 79405716 • Registration: 7741734

AMPORE is a trademark filed by Oxford Nanopore Technologies Plc on May 23, 2024. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Oxford Nanopore Technologies Plc

Gosling Building,

Entity Type: 99

Trademark Details

Filing Date

May 23, 2024

Registration Date

April 1, 2025

Published for Opposition

February 11, 2025

Goods & Services

Medical and veterinary testing and diagnostic apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; electrowetting devices for medical and veterinary purposes; apparatus and instruments for automating the extraction and preparation of test samples for medical and veterinary purposes; portable medical and veterinary testing and diagnostic apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; cartridges for test samples, for medical purposes; reaction units containing chemical reagents, namely, reaction systems for medical testing purposes; Nanopore sensing devices for medical and veterinary purposes

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 19, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 2, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 2, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 15, 2025 FINV
GENERIC MADRID TRANSACTION SENT TO IB
Oct 17, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Oct 17, 2025 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 2, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 1, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 1, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 17, 2025 CNSA
REFUSAL PROCESSED BY IB
Jan 10, 2025 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 8, 2025 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 22, 2024 RFCS
REFUSAL PROCESSED BY MPU
Dec 22, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 11, 2024 RFCR
NON-FINAL ACTION WRITTEN
Dec 10, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 19, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 16, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 3, 2024 REPR